Tus kws kho mob
QP20-19 Pharmacy Benefit Exclusion for Ultomiris (ravulizumab-cwvz) IV Injection
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 13, 2019
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1911 - 1920 ntawm 4269
Tus kws kho mob
QP22-19 Pharmacy Benefit Update - New Drug-Related Step Therapy Criteria: Methotrexate Injectable
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP18-19 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Sucralfate Suspension
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP16-19 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Orilissa (elagolix)
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP19-19 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Galafold (migalastat)
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP21-19 Reminder: Blue Cross Vision Plans with the Davis Vision Network
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 27, 2019
Tus kws kho mob
2019 March Provider Press
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 22, 2019
Tus kws kho mob
QP8-19 Addition of Drugs to the Oral Tetracycline Derivatives Prior Authorization Program
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 13, 2019
Tus kws kho mob
QP12-19 Pharmacy Benefit Update - New Drug-Related Prior Authorization Criteria: Immune Globulins
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 13, 2019
Tus kws kho mob
QP15-19 Online Medical Policy Surveys for Authorizations
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 13, 2019